STAT

Opinion: Diabetic foot ulcers: a silent killer of veterans

The VA is a pioneer when it comes to detecting and treating diabetic foot ulcers and their complications. But it, and the NIH, need to invest more in research on…
Source: MARTIN BUREAU/AFP via Getty Images

Veterans who survive the horrors of war or the other dangers of military service often die years later from a silent but deadly scourge: diabetic foot ulcers, open sores or lesions that typically start on the bottom of the foot.

About 40% of people afflicted with this problem die within five years. The annual cost to America’s health care system for treating complications of these foot ulcers is greater than treating the five most common types of cancer, and are responsible for the vast majority of non-combat amputations seen among veterans. Yet too little is being done to prevent them.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks